Streetbeat News

Stock Prices

HOOK

RHHBY

RPTX

Repare Therapeutics Inc (RPTX) announced the termination of its collaboration with Roche Holdings AG (RHHBY) for the development and commercialization of camonsertib (RP-3500), effective May 7, 2024. This decision follows a review of Roche's pipeline and external factors. Repare will regain global rights to camonsertib, which is part of the ongoing Phase 1 MYTHIC trial. Despite this, Repare has received a $40 million milestone payment from Roche and expects its funds to last into mid-2026. This is Roche's second termination within a month, having previously ended a pact with HOOKIPA Pharma Inc (HOOK) for the HB-700 program.

Portfolio Pulse from Vandana Singh

February 13, 2024 | 1:43 pm

TRIP

Tripadvisor's stock price increased following the announcement of forming a Special Committee by its board to evaluate proposals.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:42 pm

TWOU

2U's shares dropped following the announcement of disappointing Q4 financial results and the issuance of Q1 and 2024 revenue guidance that fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:42 pm

TDC

Teradata shares are trading lower following the company's announcement of Q1 and FY24 EPS guidance that fell below analyst estimates.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:42 pm

ZI

ZoomInfo Technologies' shares surged following the announcement of their Q4 financial results, which exceeded expectations. The company also provided positive guidance for the future.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:42 pm

ANET

Arista Networks' shares dropped following the announcement of their Q4 financial results and future guidance.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:42 pm

CDNS

Cadence Design Systems' shares dropped following the announcement of their Q4 financial results and future guidance.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:41 pm

LSCC

Lattice Semiconductor's stock is trading lower following mixed Q4 financial results and Q1 revenue guidance that fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:41 pm

SHOP

Shopify's stock is trading lower following the announcement of its Q4 financial results and future guidance.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:40 pm

RPTX

Repare Therapeutics' stock is trading lower following the termination of a cancer drug deal with Roche, resulting in Repare regaining global rights to camonsertib.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:40 pm